相似文献
1
Management of infections due to antibiotic-resistant Streptococcus pneumoniae.
Clin Microbiol Rev. 1998 Oct;11(4):628-44. doi: 10.1128/CMR.11.4.628.
2
Management of infections caused by antibiotic-resistant Streptococcus pneumoniae.
N Engl J Med. 1994 Aug 11;331(6):377-82. doi: 10.1056/NEJM199408113310607.
3
Pneumococcal infection in children: rational antibiotic choice for drug-resistant Streptococcus pneumoniae.
Acta Paediatr Taiwan. 2003 Mar-Apr;44(2):67-74.
4
Drug-resistant Streptococcus pneumoniae: rational antibiotic choices.
Am J Med. 1999 May 3;106(5A):19S-25S; discussion 48S-52S. doi: 10.1016/s0002-9343(98)00351-9.
5
Streptococcus pneumoniae as an agent of nosocomial infection: treatment in the era of penicillin-resistant strains.
Clin Microbiol Infect. 2001;7 Suppl 4:34-42. doi: 10.1046/j.1469-0691.2001.00056.x.
6
Clinical relevance of penicillin-resistant Streptococcus pneumoniae.
Semin Respir Infect. 2002 Sep;17(3):204-14. doi: 10.1053/srin.2002.34686.
7
Antibiotic management of pneumococcal infections in an era of increased resistance.
J Paediatr Child Health. 1997 Aug;33(4):287-95. doi: 10.1111/j.1440-1754.1997.tb01602.x.
8
Antibiotic-resistant pneumococci in pediatric disease.
Microb Drug Resist. 1995 Spring;1(1):5-8. doi: 10.1089/mdr.1995.1.5.
9
Antibiotic resistance of Streptococcus pneumoniae in children with acute otitis media treatment failure.
Int J Pediatr Otorhinolaryngol. 2015 Dec;79(12):2129-33. doi: 10.1016/j.ijporl.2015.09.030. Epub 2015 Sep 30.
10
Incidence of antibiotic-resistant Streptococcus pneumoniae and beta-lactamase-positive Haemophilus influenzae in clinical isolates from patients with otitis media.
Pediatr Infect Dis J. 1996 Sep;15(9 Suppl):S3-9. doi: 10.1097/00006454-199609009-00001.
引用本文的文献
1
Molecular Profile and the Effectiveness of Antimicrobials Drugs Against and in the Diagnostic Approaches of Otitis Infection.
Infect Drug Resist. 2023 Jul 5;16:4397-4408. doi: 10.2147/IDR.S418685. eCollection 2023.
2
Antibiotic resistance pattern, capsular types, and molecular characterization of invasive isolates of Streptococcus pneumoniae in the south of Tunisia from 2012 to 2018.
BMC Microbiol. 2023 Feb 4;23(1):36. doi: 10.1186/s12866-023-02784-2.
3
activity of lactone ketolide nafithromycin (WCK 4873) against isolates enriched with macrolide-resistance phenotype collected from mainland China.
JAC Antimicrob Resist. 2022 Oct 10;4(5):dlac103. doi: 10.1093/jacamr/dlac103. eCollection 2022 Oct.
4
Examining the Efficacy of Antimicrobial Therapy in Preventing the Development of Postinfectious Glomerulonephritis: A Systematic Review and Meta-Analysis.
Infect Dis Rep. 2022 Mar 7;14(2):176-183. doi: 10.3390/idr14020022.
5
Antifungal and Larvicidal Activities of Phlorotannins from Brown Seaweeds.
Mar Drugs. 2021 Apr 16;19(4):223. doi: 10.3390/md19040223.
6
Upregulation of Glutamate Transporter 1 by Clavulanic Acid Administration and Attenuation of Allodynia and Hyperalgesia in Neuropathic Rats.
Basic Clin Neurosci. 2019 Jul-Aug;10(4):345-354. doi: 10.32598/bcn.10.4.799.2. Epub 2019 Jul 1.
7
Emergence of Ceftriaxone Resistance during a Case of Pneumococcal Meningitis with Fatal Evolution.
Antimicrob Agents Chemother. 2020 Feb 21;64(3). doi: 10.1128/AAC.01958-19.
8
Pneumonia and Streptococcus pneumoniae vaccine.
Arch Pharm Res. 2017 Aug;40(8):885-893. doi: 10.1007/s12272-017-0933-y. Epub 2017 Jul 22.
9
In silico study on Penicillin derivatives and Cephalosporins for upper respiratory tract bacterial pathogens.
3 Biotech. 2014 Jun;4(3):241-251. doi: 10.1007/s13205-013-0147-z. Epub 2013 Jun 11.
10
Differences in antibiotic-induced oxidative stress responses between laboratory and clinical isolates of Streptococcus pneumoniae.
Antimicrob Agents Chemother. 2015 Sep;59(9):5420-6. doi: 10.1128/AAC.00316-15. Epub 2015 Jun 22.
本文引用的文献
1
Clinical characteristics and outcome of children with pneumonia attributable to penicillin-susceptible and penicillin-nonsusceptible Streptococcus pneumoniae.
Pediatrics. 1998 Dec;102(6):1369-75. doi: 10.1542/peds.102.6.1369.
2
Three-year multicenter surveillance of pneumococcal meningitis in children: clinical characteristics, and outcome related to penicillin susceptibility and dexamethasone use.
Pediatrics. 1998 Nov;102(5):1087-97. doi: 10.1542/peds.102.5.1087.
3
Three-year multicenter surveillance of systemic pneumococcal infections in children.
Pediatrics. 1998 Sep;102(3 Pt 1):538-45. doi: 10.1542/peds.102.3.538.
4
Pyogenic bacterial pneumonia in human immunodeficiency virus-infected inpatients: a clinical, radiological, microbiological, and epidemiological study.
Clin Infect Dis. 1998 Apr;26(4):964-71. doi: 10.1086/513944.
5
Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America.
Clin Infect Dis. 1998 Apr;26(4):811-38. doi: 10.1086/513953.
6
Comparative in vitro killing activities of meropenem, imipenem, ceftriaxone, and ceftriaxone plus vancomycin at clinically achievable cerebrospinal fluid concentrations against penicillin-resistant Streptococcus pneumoniae isolates from children with meningitis.
Antimicrob Agents Chemother. 1998 Apr;42(4):942-4. doi: 10.1128/AAC.42.4.942.
7
Penetration of ceftriaxone into the middle ear fluid of children.
Pediatr Infect Dis J. 1998 Mar;17(3):258-60. doi: 10.1097/00006454-199803000-00022.
8
Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media.
Pediatr Infect Dis J. 1998 Feb;17(2):149-56. doi: 10.1097/00006454-199802000-00014.
9
Complicated parapneumonic effusions in children caused by penicillin-nonsusceptible Streptococcus pneumoniae.
Pediatrics. 1998 Mar;101(3 Pt 1):388-92. doi: 10.1542/peds.101.3.388.
10
Breakthrough bacteremia and meningitis during treatment with cephalosporins parenterally for pneumococcal pneumonia.
J Pediatr. 1998 Jan;132(1):174-6. doi: 10.1016/s0022-3476(98)70510-4.
Zotero 插件